Sunderland Joint Formulary
NHS Sunderland Clinical Commissioning Group
South Tyneside and Sunderland NHS Foundation Trust

 
back
6 Endocrine system


06-06-02 Bisphosphonates

Alendronic Acid
First Choice
Tablets: 10mg, 70mg

View adult BNF  View SPC online
Risedronate
Second Choice
Tablets: 5mg, 30mg, 35mg

View adult BNF  View SPC online
Ibandronic Acid
Formulary
Tablets: 50mg

Pre-filled syringe*: 3mg/3mL

*Only for use where oral bisphosphonates are not appropriate (not tolerated, contra-indicated because of upper gastro-intestinal problems or insufficiently effective).

Green + View adult BNF  View SPC online
Sodium Clodronate
Formulary
Capsules: 400mg*
*For breast pain/breast cancer/myeloma patients only

Green + View adult BNF  View SPC online
Alendronic Acid Binosto
Formulary

Effervescent tablets: 70mg


View adult BNF  View SPC online
Disodium Pamidronate
Formulary
IV infusion: 15mg/1mL, 15 mg/5mL, 30 mg/2mL, 30 mg/10mL, 60 mg/4mL, 60 mg/10mL, 90 mg/6mL, 90 mg/10mL
Injection: 15mg, 30mg, 90mg

Red View adult BNF  View SPC online
Zoledronic Acid Aclasta®
Formulary
Infusion: 50mcg/1mL (Aclasta®)

For the treatment of postmenopausal osteoporosis, osteoporosis in men and Paget’s disease

N.B. prescribe by brand name (Aclasta®) to avoid confusion with a different strength product used to treat hypercalcaemia of malignancy and the prevention of skeletal events in patients with metastatic breast cancer.

Red View adult BNF  View SPC online
Zoledronic Acid Zometa
Formulary
Concentrate for intravenous infusion, vial: 4mg

Indication:prevention of treatment associated osteoporosis and to reduce the risk of recurrence in post-menopausal patients with early breast cancer (note: unlicensed for this indication)

Red View adult BNF  View SPC online
Disodium Etidronate Didronel®
Non Formulary

View adult BNF  View SPC online
Tiludronic Acid Skelid®
Non Formulary

View adult BNF  View SPC online